Company:  PASITHEA THERAPEUTICS COR ... (KTTA)
Form Type:  3
Filing Date:  9/14/2021 
CIK:  0001841330 
Address:  2110 NARCISSUS CT 
City, State, Zip:  VENICE, California 90291 
Telephone:  (818) 422-6172 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.14  
Change: 
-0.10 (-8.07%)  
Trade Time: 
Aug 08  
Market Cap: 
$29.78M
Trade KTTA now with 

© 2022  
Description of Business
We are a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses. Our biotech operations focus on developing drugs that target the pathophysiology underlying such disorders rather than symptomatic treatments, with the goal of developing new pharmacological agents that display significant advantages over conventional therapies with respect to efficacy and tolerability. We particularly focus on the cross-talk between the immune system and brain disorders and how immune dysregulation affects CNS function. For many years the brain was considered an "immune-privileged" organ.
Register and access this filing in:     
  FORM 3
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    REPORTING OWNERS
    SIGNATURES